EPTIS
BAM Logo

Immunosuppressant Scheme (IPT)

EPTIS factsheet 300878 | Last revision 2017-04-20 | URL: https://www.eptis.bam.de/pts300878 https://www.eptis.bam.de/pts300878

PT provider
PT provider LGC Standards Proficiency Testing LGC Standards Proficiency Testing
Based in United Kingdom
Language(s) English
Remarks
Keywords
Product groups Pharmaceutical products, drugs
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Human blood Ciclosporin -
Tacrolimus -
Sirolimus -
Everolimus -
Human plasma Mycophenolic acid -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Please see current application form and scheme description for accredited and non-accredited status of test materials and analytes.

Operation is commissioned / requested by
Fees and frequency
Participation fee Depending on sample taken
Regularly operated Yes ((12 rounds per annum))
Year of first operation
Contact details of the PT provider
Provider Contact person
LGC Standards Proficiency Testing
1 Chamberhall Business Park, Chamberhall Green,
BL9 0AP Bury Lancashire
United Kingdom

Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Web: http://www.lgcstandards.com http://www.lgcstandards.com
Mr Savvas Xystouris
Phone: +44 (0)161 762 2500
Fax: +44 (0)161 762 2501
Email: savvas.xystouris@lgcgroup.com savvas.xystouris@lgcgroup.com
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21